Adaptive Biotechnologies ... (ADPT)

NASDAQ: ADPT · Real-Time Price · USD

7.37

0.01 (0.14%)

At close: May 01, 2025, 3:59 PM

8.08

9.63%

Pre-market: May 02, 2025, 07:00 AM EDT

Adaptive Biotechnologies Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-159.59M	-225.25M	-200.37M	-207.3M	-146.23M	-68.61M	-46.45M	-42.83M
Depreciation & Amortization	19.26M	22.23M	20.92M	13.95M	8.47M	7.79M	6M	5.8M
Stock-Based Compensation	53.61M	62.91M	55.48M	43.25M	24.76M	13.12M	11.15M	7.01M
Other Working Capital	-16.32M	-44.2M	-56.83M	-49.48M	-43.66M	266.41M	-1.32M	1.49M
Other Non-Cash Items	8.97M	29.97M	11.57M	6.95M	3.34M	43K	5K	6K
Deferred Income Tax	n/a	n/a	n/a	7.23M	773K	-1.88M	-1.24M	637K
Change in Working Capital	-17.45M	-46.18M	-71.55M	-56.82M	-40.8M	254.93M	-1.72M	-5.47M
Operating Cash Flow	-95.21M	-156.32M	-183.94M	-192.73M	-149.68M	205.4M	-32.26M	-34.86M
Capital Expenditures	-3.66M	-10.7M	-16.35M	-61.75M	-18.8M	-11.2M	-6.32M	-2.51M
Cash Acquisitions	n/a	n/a	-19.25M	-181.21M	98.24M	470.5M	19K	85K
Purchase of Investments	-244.26M	-429.56M	-278.78M	-316.54M	-694.97M	-884.22M	-146.5M	-125.18M
Sales Maturities Of Investments	325.71M	569.9M	298.03M	559.5M	596.72M	413.72M	153.54M	163.91M
Other Investing Acitivies	n/a	-1	19.25M	181.21M	-98.24M	-470.5M	19K	122K
Investing Cash Flow	77.79M	129.65M	2.9M	181.21M	-117.04M	-481.7M	736K	36.43M
Debt Repayment	n/a	n/a	124.38M	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	241K	2.25M	7.89M	27.15M	21.43M	-934K	1.25M	207K
Financial Cash Flow	241K	2.25M	132.26M	27.15M	293.59M	319.92M	1.25M	50.03M
Net Cash Flow	-17.18M	-24.43M	-48.77M	15.63M	26.86M	43.62M	-30.27M	51.61M
Free Cash Flow	-98.88M	-167.02M	-200.29M	-254.47M	-168.49M	194.2M	-38.58M	-37.36M